Cargando…
Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer
Hypoxia-inducible factors (HIFs) induced by reduced O(2) availability activate the transcription of target genes encoding proteins that play important roles in communication between cancer and stromal cells. Cancer cells were incubated under hypoxic conditions: H1299, A549 (NSCLC); Hep3B, HepG2 (HCC...
Autores principales: | Shin, Dong Hoon, Jo, Jeong Yeon, Kim, Sun Ha, Choi, Minyoung, Han, Chungyong, Choi, Beom K., Kim, Sang Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563676/ https://www.ncbi.nlm.nih.gov/pubmed/32847073 http://dx.doi.org/10.3390/cancers12092402 |
Ejemplares similares
-
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
por: Shin, Dong Hoon, et al.
Publicado: (2023) -
USP12 promotes breast cancer angiogenesis by maintaining midkine stability
por: Sheng, Bin, et al.
Publicado: (2021) -
Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target
por: Han, Suji, et al.
Publicado: (2019) -
Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target
por: Han, Suji, et al.
Publicado: (2020) -
Midkine in Inflammation
por: Weckbach, Ludwig T., et al.
Publicado: (2011)